Strategic partnerships Nuo Therapeutics has an established pattern of partnering with large medical device and wound care players, including Smith & Nephew for exclusive private label distribution of CENTRIO PRP System, signaling a receptive channel for co-branded or distributed biodynamic wound care solutions.

Commercial scale potential With a commercial stage profile, a registered use case across chronic wounds, and prior sales organization development to over 400 representatives, there is a demonstrated capacity to scale field sales and accelerate market access for new PRP/biodynamic products.

Clinical and market demand Aurix leverages patient-derived platelets and plasma to jumpstart healing in diabetic foot ulcers, venous leg ulcers, and pressure injuries, aligning with high-need, large-t solution areas that drive recurring demand for advanced wound care technologies.

Strategic fundraising & partnerships Past financial activities with Deerfield Management and Pacific Medical indicate openness to strategic investors and distribution partners, suggesting opportunities for co-development financing, equity partnerships, or new distribution agreements to expand footprint.

Technology and IP leverage Proprietary biodynamic hematogel technology and integration with established channels present opportunities to upsell to orthopedic and sports medicine markets through orthobiologics portfolios and private-label collaborations.